普雷斯蒂奇 2026年季度报告

20-1297589(I.R.S. Employer Identification No.) Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Yes☒No Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company.See the definitions of “large accelerated filer,” “accelerated filer,” “smaller Accelerated Filer☐Smaller Reporting Company☐Emerging Growth Company☐ Large Accelerated FilerNon-Accelerated Filer If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes☐No☒ Prestige Consumer Healthcare Inc.Form 10-QIndex Prestige Consumer Healthcare Inc.Condensed Consolidated Balance Sheets(Unaudited) December 31,2025March 31, 2025 Prestige Consumer Healthcare Inc.Notes to Condensed Consolidated Financial Statements (unaudited) 1.Business and Basis of Presentation Nature of Business Prestige Consumer Healthcare Inc. (referred to herein as the “Company” or “we,” which reference shall, unless the context requiresotherwise, be deemed to refer to Prestige Consumer Healthcare Inc. and all of its direct and indirect 100% owned subsidiaries on aconsolidated basis) is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (“OTC”)health and personal care products to mass merchandisers, drug, food, dollar, convenience and club stores and e-commerce channels in Economic EnvironmentThere has been economic uncertainty in the United States and globally due to several factors, including evolving fiscal policy, global supply chain constraints, changes in interest rates, a high inflationary environment, geopolitical events and evolving U.S. andinternational trade restrictions and tariffs. We expect economic conditions will continue to be highly volatile and uncertain, putpressure on prices and supply, and could affect demand for our products. We have continued to see changes in the purchasing patterns The volatile environment has impacted the supply of labor and raw materials and exacerbated rising input costs. We have and maycontinue to experience shortages, delays and backorders for certain ingredients and products, difficulty scheduling shipping for ourproducts, as well as price increases from many of our suppliers for both shipping and product costs. Certain of our third-partymanufacturers are currently having, and have had in the past, difficulty meeting demand, which is and has caused shortages of ourproducts, particularly eye care products. These shortages have negatively impacted our results of operations, and we expect furthershortages will continue to have a negative impact on our sales. If conditions cause further disruption in the global supply chain, theavailability of labor and materials or otherwise further increase costs, it may materially affect our operations and those of third parties Basis of Presentation The unaudited Condensed Consolidated Financial Statements presented herein have been prepared in accordance with accountingprinciples generally accepted in the United States of America (“GAAP”) for interim financial reporting and the instructions to Form10-Q and Article 10 of Regulation S-X.Accordingly, they do not include all of the information and footnotes required by GAAP forcomplete financial statements.All significant intercompany transactions and balances have been eliminated in consolidation.In theopinion of management, these Condensed Consolidated Financial Statements include all adjustments, consisting of normal recurringadjustments, that are considered necessary for a fair statement of our consolidated financial position, results of operations and cashflows for the interim periods presented.Our fiscal year ends on March 31st of each year. References in these Condensed Consolidated Use of EstimatesThe preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, aswell as the reported amounts of revenues and expenses during the reporting period.Although these estimates are based on ourknowledge